Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38, which is overexpressed in multiple myeloma cells. From Wikipedia
New findings show patients with lower physical function gain the most survival and progression benefits, prompting calls for integrating patient-reported outcomes into oncology care.
